Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Consort makes ‘logical’ £230m vertical integration move

This article was originally published in Clinica

Executive Summary

Drug delivery specialist Consort Medical has agreed to acquire fellow UK firm Aesica Pharmaceuticals for £230m ($373m), giving it a stronger foothold in the pharmaceutical supply chain. The move for the contract development and manufacturing organization (CDMO) is “logical,” according to Canaccord Genuity analyst Julie Simmonds, “giving the group a wider contract service offering.”





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts